Kura Oncology Inc. (NASDAQ:KURA)’s share price shot up 5.4% during mid-day trading on Thursday . The company traded as high as $2.77 and last traded at $2.74, with a volume of 77,425 shares. The stock had previously closed at $2.60.

A number of research firms have recently issued reports on KURA. Oppenheimer Holdings Inc. reiterated an “outperform” rating and issued a $16.00 price objective on shares of Kura Oncology in a report on Tuesday, June 21st. Zacks Investment Research cut Kura Oncology from a “buy” rating to a “hold” rating in a report on Tuesday, May 17th. Finally, Citigroup Inc. cut their price objective on Kura Oncology from $19.00 to $12.00 and set a “buy” rating for the company in a report on Monday, March 21st.

The stock’s market capitalization is $51.08 million. The stock has a 50-day moving average price of $2.91 and a 200-day moving average price of $4.08.

Kura Oncology (NASDAQ:KURA) last announced its earnings results on Wednesday, May 11th. The company reported ($0.36) EPS for the quarter, missing the Zacks’ consensus estimate of ($0.35) by $0.01. On average, equities analysts anticipate that Kura Oncology Inc. will post ($1.70) earnings per share for the current fiscal year.

Kura Oncology, Inc is a clinical-stage biopharmaceutical company. The Company is engaged in discovering and developing personalized therapeutics for the treatment of solid tumors and blood cancers. Its segment is engaged in the discovery and development of personalized therapeutics for the treatment of solid tumors and blood cancers.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.